A Patient's Perspective on Demodex Blepharitis Treatment

A panel of experts specializing in eye care speak with Mr. Dermott Ryan, a patient with Demodex blepharitis, to gain a better understanding of how the disease impacts patients. Mr. Ryan provides valuable insight and backs the efficacy of lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.